A New York telepsychiatry provider with 300 full-time licensed psychiatrists treating anxiety, bipolar disorder, depression, OCD and PTSD in 43 states.

That employing psychiatrists full time and accepting insurance lets Talkiatry scale value-based mental health care that independent-contractor models cannot.

$130M Series C in a mix of debt and equity, with Perceptive Advisors and debt from Banc of California; $245M raised in total.

Talkiatry was founded in 2020 in New York. It is in-network with more than 60 health plans, including Aetna, Blue Cross Blue Shield, United Healthcare, Cigna and Humana, and most of its physician-level providers are W-2 staff, unlike an industry that has historically used independent contractors.

In June 2024 it announced a $130 million Series C led by Andreessen Horowitz, a mix of debt and equity, with Perceptive Advisors participating and Banc of California providing debt. CEO Robert Krayn told Axios it had been weighing acquisition targets alongside fundraising the previous October, and told the Wall Street Journal it was preparing for an eventual IPO.

Insurance roadblocks limit access to mental health care despite large government spending, per Axios.

Being in-network with 60+ plans gives patients insurance coverage for psychiatric care.

Employing psychiatrists on W-2s departs from the industry's contractor norm.

A debt-and-equity mix funds scale and acquisitions ahead of a possible IPO.

Employing clinicians and joining insurance networks is slower than the contractor model, which is why the bet needs a large, partly debt-funded round to scale.

As of 2024-06-18 Talkiatry had closed the $130M Series C and had 300 psychiatrists in 43 states; the IPO preparation is the CEO's statement to the Wall Street Journal, and no timeline was given.

FOLLOW THE EVIDENCE

The sources

  1. The BFD: Talkiatry banks $130M Series C axios.com